AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Avita Therapeutics

1.120

+0.0050.45%

Volume:65.23K

Turnover:73.59K

Market Cap:170.76M

PE:-0.05

High:1.140

Open:1.130

Low:1.120

Close:1.115

52wk High:3.380

52wk Low:1.000

Shares:152.47M

Float Shares:5.34M

Volume Ratio:0.19

T/O Rate:1.22%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-20.499

EPS(LYR):-27.031

ROE:-1746.27%

ROA:-36.33%

PB:-18.12

PE(LYR):-0.04

Loading ...

Overview Company News Filings

Stock Track | Avita Therapeutics Plummets 22.58% on CEO Change and Q3 Revenue Guidance

Avita Medical Appoints Interim CEO, Issues Q3 Revenue Guidance; Shares Tumble 20%

MT Newswires Live

ASX Midday Sector Update: Energy Stocks Up, Healthcare Declines

MT Newswires Live

BUZZ-ASX-listed Avita Medical rises as data shows efficiency of its medical device

Shares of AVITA Medical Rise After Registry Data Shows Use of Cell Harvesting Device Reduces Hospital Stay

MT Newswires Live

Stock Track | Avita Therapeutics Plummets 20% as Q2 Results Miss Estimates and 2025 Outlook Slashed

Avita Medical Posts Narrower Q2 Loss, Higher Revenue; Lowers 2025 Outlook

MT Newswires Live

Avita Medical Chair to Step Down, Successor Named

MT Newswires Live

Stock Track | Avita Therapeutics Soars 5.26% as Study Shows Recell System Reduces Hospital Stays for Burn Patients

Stock Track | Avita Therapeutics Soars 5.26% as Study Shows Recell System Reduces Hospital Stays for Burn Patients

Avita Medical Says Data Show Recell Reduced Length of Hospital Stay for Burn Patients

MT Newswires Live

Avita Medical Says Dermal Matrix Shows 'Significantly' Faster Wound Bed Vascularization, Autograft Readiness

MT Newswires Live

ASX Biggest Losers

MT Newswires Live

Stock Track | Avita Therapeutics Plummets 20.74% as Q1 Earnings Miss Analyst Expectations

Avita Medical's Loss Narrows in Q1 as Revenue Grows; Shares Down 20%

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AVH.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AVH.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"AVH.AU\",,,,,undefined,":{"symbol":"AVH.AU","market":"AU","secType":"STK","nameCN":"Avita Therapeutics","latestPrice":1.12,"timestamp":1770700320000,"preClose":1.115,"halted":0,"volume":65227,"delay":0,"changeRate":0.00448430493273553,"nameEN":"Avita Therapeutics","floatShares":5344505,"shares":152465555,"eps":-20.49862266744348,"marketStatus":"Not Yet Opened","change":0.005,"latestTime":"02-10 16:12:00 AEDT","open":1.13,"high":1.14,"low":1.12,"amount":73593,"amplitude":0.017937,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-20.49862266744348,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770764400000},"marketStatusCode":0,"adr":0,"adrRate":8,"exchange":"ASX","adjPreClose":1.115,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":0.18639715428315284,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"AVH.AU\",,,,,undefined,":{"symbol":"AVH.AU","floatShares":5344505,"roa":"-36.33%","roe":"-1746.27%","lyrEps":-27.030799,"volumeRatio":0.18639715428315284,"shares":152465555,"dividePrice":0,"high":1.14,"amplitude":0.017937,"preClose":1.115,"low":1.12,"week52Low":1,"pbRate":"-18.12","psRate":"1.67","week52High":3.38,"institutionHeld":0,"latestPrice":1.12,"eps":-20.49862266744348,"divideRate":0,"volume":65227,"delay":0,"ttmEps":-20.49862266744348,"open":1.13,"prevYearClose":1.05,"prevWeekClose":1.09,"prevMonthClose":1.23,"prevQuarterClose":1.05,"fiveDayClose":1.22,"twentyDayClose":1.055,"sixtyDayClose":1.16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVH.AU\",params:#limit:5,,,undefined,":[{"date":"2023-08-10","symbol":"AVH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1691625600000,"name":null,"time":"","dateTimestamp":1691589600000,"actualEps":null},{"date":"2023-05-11","symbol":"AVH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1683763200000,"name":null,"time":"","dateTimestamp":1683727200000,"actualEps":null},{"date":"2023-02-23","symbol":"AVH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1677106800000,"name":null,"time":"","dateTimestamp":1677070800000,"actualEps":null},{"date":"2022-11-10","symbol":"AVH.AU","type":"earning","reportTimeType":"post","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1668034800000,"name":null,"time":"Post Market","dateTimestamp":1667998800000,"actualEps":null},{"date":"2022-08-11","symbol":"AVH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1660176000000,"name":null,"time":"","dateTimestamp":1660140000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVH.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AVH.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1125214991","title":"Stock Track | Avita Therapeutics Plummets 22.58% on CEO Change and Q3 Revenue Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=1125214991","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125214991?lang=en_us&edition=fundamental","pubTime":"2025-10-17 07:28","pubTimestamp":1760657293,"startTime":"0","endTime":"0","summary":"Shares of Avita Therapeutics (ASX:AVH) plummeted 22.58% in Friday's trading session following the announcement of a leadership change and preliminary third-quarter revenue guidance. The significant...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["AVH.AU"],"gpt_icon":0},{"id":"2576774070","title":"Avita Medical Appoints Interim CEO, Issues Q3 Revenue Guidance; Shares Tumble 20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576774070","media":"MT Newswires Live","labels":["executive","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576774070?lang=en_us&edition=fundamental","pubTime":"2025-10-17 07:24","pubTimestamp":1760657068,"startTime":"0","endTime":"0","summary":"Avita Medical  appointed Chairman Cary Vance as interim chief executive, effective immediately, succeeding Jim Corbett, according to a Friday filing with the Australian bourse.The board will engage an executive search firm to identify a permanent CEO from internal and external candidates, the filing said.In the same filing, the company said it anticipates preliminary revenue of around AU$17 million for the third quarter ended Sept. 30.The company's shares plummeted 20% in recent Friday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","BK7508","AVH.AU"],"gpt_icon":0},{"id":"2567419405","title":"ASX Midday Sector Update: Energy Stocks Up, Healthcare Declines","url":"https://stock-news.laohu8.com/highlight/detail?id=2567419405","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567419405?lang=en_us&edition=fundamental","pubTime":"2025-09-15 11:30","pubTimestamp":1757907014,"startTime":"0","endTime":"0","summary":"Energy stocks advanced 0.5% at midday Monday, as investors look out for easing of the monetary policy in the US this week.Condor Energy  said a gas market and commercialization study for its Piedra Redonda gas field offshore Peru confirmed multiple pathways to monetization and identified immediate local and regional market opportunities, including gas-to-power and compressed natural gas supply to northern Peru and Ecuador.Meanwhile, healthcare fell more than 1%.Avita Medical  said it received the CE Mark approval under the European Union Medical Device Regulation for Recell GO, its burn and wound recovery medical product. It said that it will now begin commercialization of Recell GO in select European countries, including Germany, Italy, and the UK.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4137","HCSG","BK7142","AVH.AU","BK7067","CND.AU","BK7508"],"gpt_icon":0},{"id":"2565536167","title":"BUZZ-ASX-listed Avita Medical rises as data shows efficiency of its medical device","url":"https://stock-news.laohu8.com/highlight/detail?id=2565536167","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565536167?lang=en_us&edition=fundamental","pubTime":"2025-09-05 12:23","pubTimestamp":1757046184,"startTime":"0","endTime":"0","summary":"BUZZ-ASX-listed Avita Medical rises as data shows efficiency of its medical device** ASX-listed shares of AVITA Medical AVH.AX rises as much as 3% to A$1.37, highest since August 29** U.S.-based biotech firm says analysis of U.S. national burn registry data shows 36% shorter hospital stays in adults with deep second-degree burns treated with RECELL vs traditional skin grafting** RECELL System is U.S. FDA-approved device used to treat thermal burns, trauma wounds** AVH last up 1.1%, trimming YTD losses to 68.4%  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250905:nL4N3US09T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","RCEL","BK4139","BK7067","AVH.AU"],"gpt_icon":0},{"id":"2565587298","title":"Shares of AVITA Medical Rise After Registry Data Shows Use of Cell Harvesting Device Reduces Hospital Stay","url":"https://stock-news.laohu8.com/highlight/detail?id=2565587298","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565587298?lang=en_us&edition=fundamental","pubTime":"2025-09-05 09:37","pubTimestamp":1757036236,"startTime":"0","endTime":"0","summary":"Shares of AVITA Medical  rose nearly 2% in recent Friday trade after the company said in a Thursday statement that the data from the US national burn registry showed the use of its cell harvesting device RECELL reduced hospital stays by an average of 36% compared to traditional skin grafts in adult patients with second-degree burns.The data also showed potential cost savings of over $42,000 per patient, and suggested that shorter hospital stays could allow hospitals to treat 13 more patients per bed each year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AVH.AU","BK7508","BK7067"],"gpt_icon":0},{"id":"1170837253","title":"Stock Track | Avita Therapeutics Plummets 20% as Q2 Results Miss Estimates and 2025 Outlook Slashed","url":"https://stock-news.laohu8.com/highlight/detail?id=1170837253","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170837253?lang=en_us&edition=fundamental","pubTime":"2025-08-08 08:02","pubTimestamp":1754611340,"startTime":"0","endTime":"0","summary":"Shares of Avita Therapeutics (AVH.AU) plummeted 20% in Friday's trading session following the release of disappointing second-quarter results and a significant downward revision to its full-year 2025...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["AVH.AU"],"gpt_icon":0},{"id":"2557659202","title":"Avita Medical Posts Narrower Q2 Loss, Higher Revenue; Lowers 2025 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2557659202","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557659202?lang=en_us&edition=fundamental","pubTime":"2025-08-08 07:07","pubTimestamp":1754608046,"startTime":"0","endTime":"0","summary":"Avita Medical  reported Friday a second-quarter loss of $0.38 per share, compared with $0.6 a year earlier.Analysts polled by Visible Alpha expected a loss of $0.27.Revenue for the quarter ended June 30 was $18.4 million, compared with $15.2 million a year earlier.Analysts surveyed by Visible Alpha expected $21.8 million.The company lowered its full-year 2025 revenue guidance to a range of $76 million to $81 million, from $100 million to $106 million, reflecting growth of 19% to 27% from the prior year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AVH.AU"],"gpt_icon":0},{"id":"2557533832","title":"Avita Medical Chair to Step Down, Successor Named","url":"https://stock-news.laohu8.com/highlight/detail?id=2557533832","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557533832?lang=en_us&edition=fundamental","pubTime":"2025-08-07 12:52","pubTimestamp":1754542377,"startTime":"0","endTime":"0","summary":"Avita Medical (ASX:AVH) said Chairman Lou Panaccio stepped down, and Cary Vance has been appointed to the role, effective Thursday, according to a same-day filing with the Australian bourse.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XKO.AU","XJO.AU","BK7508","AVH.AU","BK7067","XAO.AU"],"gpt_icon":0},{"id":"1125134097","title":"Stock Track | Avita Therapeutics Soars 5.26% as Study Shows Recell System Reduces Hospital Stays for Burn Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=1125134097","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125134097?lang=en_us&edition=fundamental","pubTime":"2025-06-10 08:14","pubTimestamp":1749514479,"startTime":"0","endTime":"0","summary":"Avita Therapeutics  saw its stock soar 5.26% in Tuesday's trading session following the release of promising data for its Recell system. The surge came after researchers presented findings at the annual meeting of the British Burn Association, demonstrating significant benefits for burn patients treated with the company's innovative technology.The positive results from this large-scale study could potentially boost the adoption of Avita's Recell system in burn treatment centers worldwide. As hea","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["AVH.AU"],"gpt_icon":0},{"id":"1109280284","title":"Stock Track | Avita Therapeutics Soars 5.26% as Study Shows Recell System Reduces Hospital Stays for Burn Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=1109280284","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109280284?lang=en_us&edition=fundamental","pubTime":"2025-06-10 08:14","pubTimestamp":1749514460,"startTime":"0","endTime":"0","summary":"Avita Therapeutics  saw its stock price surge 5.26% in Tuesday's trading session following the release of positive data for its Recell system. The company announced that researchers presented compelling evidence at the annual meeting of the British Burn Association, demonstrating significant benefits for burn patients treated with the Recell system.These findings underscore the potential of Avita's Recell system to revolutionize burn treatment, offering substantial benefits to both patients and ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | Avita Therapeutics Soars 5.26% as Study Shows Recell System Reduces Hospital Stays for Burn Patients","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["AVH.AU"],"gpt_icon":0},{"id":"2542199356","title":"Avita Medical Says Data Show Recell Reduced Length of Hospital Stay for Burn Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2542199356","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542199356?lang=en_us&edition=fundamental","pubTime":"2025-06-10 08:02","pubTimestamp":1749513772,"startTime":"0","endTime":"0","summary":"Avita Medical  said researchers presented data at the annual meeting of the British Burn Association demonstrating reduced length of hospital stays among burn patients treated with the Recell system, according to a Tuesday Australian bourse filing.The study, representing the largest real-world analysis of skin cell suspension autograft, or Recell, analyzed registry data from over 6,300 patients treated with Recell between 2019 and 2024.For patients with burns covering less than 30% total body surface area, their hospital stay was reduced by 6.2 days or about 36% if they were treated with Recell Spray-On Skin Cells alone, compared with patients treated with split-thickness autografts.The reduced lengths of stay led to cost savings of around AU$300 million over the five-year study period.The session was titled \"The Clinical Impact of Skin Cell Suspension Autograft from a National Registry Perspective,\" and the study was presented by Jeffrey Carter of Louisiana State University Health and","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","BK7508","AVH.AU"],"gpt_icon":0},{"id":"2541500142","title":"Avita Medical Says Dermal Matrix Shows 'Significantly' Faster Wound Bed Vascularization, Autograft Readiness","url":"https://stock-news.laohu8.com/highlight/detail?id=2541500142","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541500142?lang=en_us&edition=fundamental","pubTime":"2025-06-06 06:47","pubTimestamp":1749163648,"startTime":"0","endTime":"0","summary":"Avita Medical (ASX:AVH) published clinical results that showed two patients with complex full-thickness hand wounds treated with its collagen-based dermal matrix, Cohealyx, achieved autograft readines","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AVH.AU","BK7067","BK7508"],"gpt_icon":0},{"id":"2534819114","title":"ASX Biggest Losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2534819114","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534819114?lang=en_us&edition=fundamental","pubTime":"2025-05-09 10:43","pubTimestamp":1746758590,"startTime":"0","endTime":"0","summary":"Here are the 10 ASX-listed companies with the biggest losses on Friday.Saferoads Holdings : -33%, AU$0.18MedAdvisor : -23%, AU$0.10Legend Mining : -22%, AU$0.007Atomos : -20%, AU$0.004White Energy Company : -19%, AU$0.03Paterson Resources : -18%, AU$0.014Avita Medical : -17%, AU$2.47FBR Limited : -17%, AU$0.005Hawthorn Resources : -16%, AU$0.051Middle Island Resources : -14%, AU$0.018","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7003","BK7094","BK7508","BK7090","WEC.AU","FBR.AU","AMS.AU","SRH.AU","BK7067","BK7083","AVH.AU","MDI.AU","PSL.AU","BK7077","MDR.AU","BK7095","LEG.AU","BK7104","HAW.AU"],"gpt_icon":1},{"id":"1178729079","title":"Stock Track | Avita Therapeutics Plummets 20.74% as Q1 Earnings Miss Analyst Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=1178729079","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178729079?lang=en_us&edition=fundamental","pubTime":"2025-05-09 09:08","pubTimestamp":1746752904,"startTime":"0","endTime":"0","summary":"Shares of Avita Therapeutics  plummeted 20.74% in Friday's trading session following the release of its first-quarter earnings report. The sharp decline came as the company's financial results fell short of analyst expectations, despite showing year-over-year improvements.Avita Medical, the parent company of Avita Therapeutics, reported a narrower loss of $0.53 per diluted share for the quarter ended March 31, compared to a loss of $0.73 per share in the same period last year. However, this figu","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | Avita Therapeutics Plummets 20.74% as Q1 Earnings Miss Analyst Expectations","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["AVH.AU"],"gpt_icon":0},{"id":"2534119703","title":"Avita Medical's Loss Narrows in Q1 as Revenue Grows; Shares Down 20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534119703","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534119703?lang=en_us&edition=fundamental","pubTime":"2025-05-09 09:05","pubTimestamp":1746752713,"startTime":"0","endTime":"0","summary":"Avita Medical  reported Friday that its first quarter loss narrowed to $0.53 per diluted share from $0.73 per diluted share a year earlier.Analysts polled by Visible Alpha expected a loss of $0.45 per diluted share.Total revenue for the three months ended March 31 was $18.5 million, compared with $11.1 million a year earlier. Analysts surveyed by Visible Alpha expected $20.1 million.The company reaffirmed its full-year 2025 guidance, anticipating commercial revenue of between $100 million and $106 million, indicating a 55% to 65% growth from a year earlier.Shares fell nearly 20% in morning trade Friday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AVH.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}]}}